Sign inJoin waitlistJoin the waitlist

Jonathan Schoenfeld

Director, Melanoma Radiation Oncology · Mass General Brigham

Credentials: · · · ·

History

Mass General Brigham
Present

University of Cambridge
2013–2014
Radiation Oncology
Mass General Brigham
2009–2013
Transitional Year
Memorial Sloan Kettering Cancer Center
2008–2009
Harvard T.H. Chan School of Public Health
Harvard Medical School
2004–2008

Research

Using immunotherapy to boost the abscopal effect
Review · Nature reviews. Cancer · 2018 · 1,007 citations
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
Cell · 2022 · 348 citations
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Clinical Cancer Research · 2020 · 335 citations

Danielle Margalit
58 papers
Roy Tishler
58 papers
Robert Haddad
55 papers
GH
Glenn Hanna
35 papers · 3 as a fellow
Ravindra Uppaluri
28 papers
Jochen Lorch
23 papers
NC
Nicole Chau
22 papers
Laura Goguen
20 papers
Donald Annino
19 papers
Ann Silk
15 papers
Eleni Rettig
15 papers
Emily Ruiz
14 papers

Clinical trials

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Principal investigator · Recruiting
Dana-Farber Cancer Institute
2021–2030
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Principal investigator · Recruiting · Phase 2
Jonathan Schoenfeld, MD, MPH
2021–2032
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2017–2027
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
Principal investigator · Active not recruiting · Phase 2
Dana-Farber Cancer Institute
2017–2027